Search

everythinglearnresearchcommunity

for

Search:↓

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

A reliable method was developed to measure aristolochic acid-I in rat blood.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Kawasaki Disease is rare and often missed in adults, who show different symptoms than children, and may benefit from early treatment.

Some common medications like metformin, insulin, and ACE inhibitors can lower PSA levels, while statins don't, and low dose finasteride significantly reduces PSA.

A woman developed lupus after taking hydroxyurea for two years.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Baricitinib is more effective than methotrexate for severe alopecia areata.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Tofacitinib is an effective and safe treatment for alopecia areata.

Dutasteride is as safe for the heart as finasteride.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Nanoporous silica entrapped lipid-drug complexes significantly improve the solubility and absorption of drugs that don't dissolve well in water.

Baricitinib is effective as a treatment for severe hair loss.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Baricitinib is a safe and effective treatment for severe alopecia areata.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

SARM-induced changes in the androgen receptor are specific to each ligand and affect stability and protein interactions.